India Pharma Q4 Results Preview - U.S. To Drive Performance: Systematix

For the acute focussed names, domestic sales will witness QoQ weakness on account of seasonality.

<div class="paragraphs"><p>Assortment of colorful pills arranged for photograph. (Source: freepik)</p></div>
Assortment of colorful pills arranged for photograph. (Source: freepik)
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
To continue reading this story
Subscribe to unlock & enjoy all Members-only benefits

Choose a plan

Renews automatically. Cancel anytime.
Still Not convinced ? Know More